United Kingdom
MediMusic is revolutionizing healthcare with its groundbreaking approach to utilizing music as a form of therapy. Founded in 2016 and based in the United Kingdom, the company's slogan "Prescribing music as medicine" captures the essence of its mission. Utilizing an algorithmic/AI-based music neuroscience solution, MediMusic brings the scientifically proven benefits of music to healthcare.
The company's £1.20MVenture Round investment at 22 September 2022 is a testament to the recognition and support it has garnered. Notable investors such as Finance Yorkshire, University of Hull, and Sauce Consultants have demonstrated confidence in the potential of MediMusic's innovative approach.
MediMusic's Digital Drip™ technology dynamically creates playlists to mimic the human brain's physiological response, tailoring musical journeys to reduce stress and anxiety, enhance the effects of pain medication, and elevate mood. By offering a low-cost, non-invasive, and complementary service to existing treatments, MediMusic presents a viable and measurable ROI for healthcare institutions.
With a focus on Biotechnology and Health Care industries, MediMusic stands at the forefront of integrating music and science to enhance the well-being of individuals, positioning itself as an influential player in the evolution of healthcare.
